![Thomas Schenk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Thomas Schenk served as the Chief Medical Officer at ImpediMed Ltd. from 2022 to 2023.
Prior to this, he obtained undergraduate degrees from Cornell University and Jacobs School of Medicine & Biomedical Sciences.
Former positions of Thomas Schenk
| Companies | Position | End |
|---|---|---|
| IMPEDIMED LIMITED | Chief Tech/Sci/R&D Officer | 26/09/2023 |
Training of Thomas Schenk
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImpediMed Ltd.
 ImpediMed Ltd. Medical SpecialtiesHealth Technology Develops and distributes medical devices for use clinical assessment and monitoring of human disorders and diseases | Health Technology |
Jacobs School of Medicine & Biomedical Sciences
 Jacobs School of Medicine & Biomedical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Thomas Schenk
